As of Jul 06
| -0.90 / -5.84%|
The 8 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 30.50, with a high estimate of 53.53 and a low estimate of 11.35. The median estimate represents a +110.34% increase from the last price of 14.50.
The current consensus among 8 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.